Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,65
KB0,06
PKN67,467,430,93
Msft408,85408,862,47
Nokia3,38053,44951,09
IBM167,42167,45-0,78
Mercedes-Benz Group AG74,3674,381,56
PFE25,4625,470,79
26.04.2024 19:22:46
Indexy online
AD Index online
select
AD Index online
 

  • 26.04.2024 17:35:02
ConvaTec Grp Rg (London)
Poslední obchod Změna (%) Změna (GBP) Objem obchodů (GBP)
2,58 -6,46 -0,18 24 899 977
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 26.04.2024
Popis společnosti
Obecné informace
Název společnostiConvaTec Group PLC
TickerCTEC
Kmenové akcie:Ordinary Shares
RICCTEC.L
ISINGB00BD3VFW73
Prioritní akcieRedeem. Pref. Shrs
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 10 129
Akcie v oběhu k 31.12.20232 049 789 559
MěnaUSD
Kontaktní informace
Ulice7th Floor, 20 Eastbourne Terrace
MěstoLONDON
PSČW2 6LG
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 

Business Summary: Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Its Advanced Wound Care includes advanced solutions for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories and personalized services for individuals with a stoma. Its Continence and Critical Care includes products and services for people with urinary continence issues, and other devices for critical care. Its Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, ConvaTec Group PLC revenues increased 3% to $2.14B. Net income increased from $62.9M to $130.3M. Revenues reflect Ostomy Care segment increase of 17% to $608.3M, Advanced Wound Care segment increase of 12% to $695.3M, U.S segment increase of 10% to $821.5M, Other segment increase of 1% to $828.7M.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 26.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorKarim Bitar-30.09.201930.09.2019
Chief Financial Officer, Executive DirectorJonny Mason-12.03.202231.01.2022
President and Chief Operating Officer - Global Emerging MarketsAnne Belcher-01.01.2022
President and Chief Operating Officer - Infusion CareKjersti Grimsrud-01.01.2018
President and Chief Operating Officer - Ostomy CareBruno Pinheiro-
President and Chief Operating Officer - Continence Care and Home Services GroupSeth Segel-
President and Chief Operating Officer - Advanced Wound CareDavid Shepherda-19.11.2018
Chief Human Resource Officer, Executive Vice President and ESG StewardshipNatalia Kozmina-01.06.2020
Executive Vice President, Chief Technology Officer and Head of Research and DevelopmentDivakar Ramakrishnan-21.01.2020
Executive Vice President, Chief of Corporate Strategy and Business Development, General CounselEvelyn Douglas-01.09.2023